ETFChannel.com
BMY Description — Bristol-Myers Squibb Co.

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co.'s products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. Co. manufactures products in the U.S., Puerto Rico and in four foreign countries. Co. has products in the following therapeutic classes: oncology; cardiovascular; and immunoscience. Co.'s products include: Opdivo; Eliquis; Orencia; Sprycel; Yervoy; Empliciti; Baraclude; the Reyataz Franchise; the Sustiva Franchise; and the Hepatitis C Franchise.

Company Name: 
Bristol-Myers Squibb Co.
Website: 
www.bms.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding BMY: 
108
Total Market Value Held by ETFs: 
$7,914,146,266
Total Market Capitalization: 
$93,928,000,000
% of Market Cap. Held by ETFs: 
8.43%
 ETF   BMY Weight   BMY Amount 
 VTI   0.29%   $2,556,786,692         
 VOO   0.35%   $1,821,012,748         
 IVV   0.35%   $689,166,788         
 VUG   0.35%   $336,014,585         
 VYM   0.87%   $309,122,458         
 VTV   0.34%   $290,231,207         
 VHT   2.11%   $231,145,904         
 IWD   0.38%   $158,317,422         
 QUAL   1.08%   $152,938,573         
 IWF   0.25%   $120,067,512         
List of all 108 ETFs holding BMY »
Quotes delayed 20 minutes

Buy (3.27 out of 4)
51st percentile
(ranked higher than approx. 51% of all stocks covered)

Analysts Forecast:
BMY Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding BMY | Bristol-Myers Squibb Co. | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2019, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.